Europe – Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP)...

Eleven new medicines recommended for approval EMA’s human medicines committee (CHMP) recommended eleven medicines for approval at its November 2021 meeting. Regkirona (regdanvimab) and Ronapreve (casirivimab / imdevimab) are...
European Pharmacopoeia revises general chapter on degree of coloration of liquids

Europe – Pharmeuropa 33.4 just released

All new European Pharmacopoeia (Ph. Eur.) texts and texts that have undergone technical revisions are published in Pharmeuropa for public consultation. The deadline for comments on Pharmeuropa 33.4 is...

UK – UK disposed of 600,000 AZ vaccine doses after they passed expiry date

Oxfam has described this as an “absolute scandal”, as the government did not donate the doses to poorer countries with low rates of vaccination...
European Pharmacopoeia revises general chapter on degree of coloration of liquids

Europe – EDQM Laboratory’s ISO 17025:2017 accreditation renewed

The European Directorate for the Quality of Medicines & HealthCare (EDQM) Laboratory successfully obtained the renewal of its accreditation according to the ISO/IEC 17025:2017...

Europe – Forxiga (dapagliflozin) 5mg should no longer be used for the treatment of...

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan...

UK – NICE recommends cenobamate for treatment of adult epilepsy patients in UK

The Final Appraisal Document (FAD) recommends cenobamate as an option for treating focal onset seizures with or without secondary generalised seizures, in adults with...

Europe – First-in-class medicine recommended for treatment of rare blood vessel inflammation

EMA has recommended granting a marketing authorisation in the European Union (EU) for Tavneos (avacopan), a first-in-class medicine to treat adult patients suffering from two forms...
NICE rejects Novartis’ CAR-T Kymriah for adult lymphoma

UK – NICE ‘no’ for BioMarin’s Vimizin

The draft guidance, which has been published for public consultation, follows an evaluation of new evidence on the use of Vimizin for the treatment...

UK – New drug combination highly effective in children with leukaemia

The results of the trial were published in JAMA Oncology on 11 November, which studied the treatment of APL with the combination of all-trans-retinoic...

UK – New COVID-19 vaccines could target replication proteins

The study has been published in Nature. Researchers at University College London, UK, have said that next generation vaccines for COVID-19 should aim to induce...

NOS PROCHAINES FORMATIONS